Teva Pharmaceutical Industries Ltd

Pacer Advisors, Inc. TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/24/2026

Shares

8,987

Value ($000)

280

Weight

0.0%

2019 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/24/2026	280	0.0%	8,987	12/31/2025
2025 Q3	10/15/2025	188	0.0%	9,301	9/30/2025
2025 Q2	8/12/2025	165	0.0%	9,864	6/30/2025
2025 Q1	5/6/2025	159	0.0%	10,339	3/31/2025
2024 Q4	1/22/2025	221	0.0%	10,042	12/31/2024
2024 Q3	11/12/2024	174	0.0%	9,646	9/30/2024
2024 Q2	8/13/2024	158	0.0%	9,721	6/30/2024
2024 Q1	5/10/2024	144	0.0%	10,196	3/31/2024
2023 Q4	1/16/2024	110	0.0%	10,576	12/31/2023
2023 Q3	11/13/2023	105	0.0%	10,282	9/30/2023
2023 Q2	7/12/2023	69	0.0%	9,146	6/30/2023
2023 Q1	5/2/2023	76	0.0%	8,594	3/31/2023
2022 Q4	2/6/2023	76	0.0%	8,318	12/31/2022
2021 Q4	2/3/2022	68	0.0%	8,460	12/31/2021
2021 Q3	10/15/2021	86	0.0%	8,847	9/30/2021
2021 Q2	7/21/2021	85	0.0%	8,571	6/30/2021
2021 Q1	4/5/2021	99	0.0%	8,571	3/31/2021
2020 Q4	1/20/2021	87	0.0%	9,031	12/31/2020
2020 Q3	10/19/2020	100	0.0%	11,055	9/30/2020
2019 Q4	2/10/2020	82	0.0%	8,333	12/31/2019